Symbols

ADXN

Addex Therapeutics·NASDAQ

--(--)

7.29 / 10

Outperform

Analyst coverage is absent. Fund‑flow rating is Outperform with a 7.29/10 score. Overall inflow ratio is 0.43 but trend is negative; only small‑cap inflows are positive. The flow picture suggests cautious optimism despite broader outflows.

Fund Flow Rating

Is money flowing into or out of ADXN?

ADXN holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.29/10 (Outperform).